Nimorazole
Title | Journal |
---|---|
Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010. | Emerging infectious diseases 20120601 |
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120101 |
Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy. | Frontiers in pharmacology 20120101 |
Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials. | Acta oncologica (Stockholm, Sweden) 20111001 |
[Development and use of test systems for the evaluation of sensitivity of Trichomonas vaginalisto preparations of the 5-nitroimidazole and 5-nitrofuran groups]. | Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20110101 |
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100101 |
Tinidazole in the treatment of bacterial vaginosis. | International journal of women's health 20090101 |
Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20080601 |
The nimorazole regimen in patients with head and neck cancer can increase the effect of vitamin K antagonists. | Acta oncologica (Stockholm, Sweden) 20080101 |
Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer. | Current oncology (Toronto, Ont.) 20080101 |
[The Oxygen effect: an old new target?]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20080101 |
Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials. | Breast cancer research : BCR 20080101 |
Evidence-based radiation oncology in head and neck squamous cell carcinoma. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20071001 |
The importance of radiobiology to cancer therapy: current practice and future perspectives. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20070801 |
Chemical radiosensitizers for use in radiotherapy. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20070801 |
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20070601 |
Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20070601 |
Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer. | International journal of nanomedicine 20070301 |
Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. | Anticancer research 20060101 |
Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system. | BMC cancer 20060101 |
Update on clinical radiobiology. | Biomedical imaging and intervention journal 20060101 |
Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivo. | Journal of radiation research 20051201 |
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. | The Lancet. Oncology 20051001 |
Nimorazole may increase the effect of phenprocoumon. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20050301 |
Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers. | Magnetic resonance in chemistry : MRC 20050201 |
Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia. | British journal of cancer 20040913 |
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model. | British journal of cancer 20040719 |
Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20040601 |
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. | Lancet (London, England) 20030920 |
Nitroheterocyclic drugs with broad spectrum activity. | Parasitology research 20030601 |
Treatment of head and neck cancer with CHART and nimorazole: phase II study. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20030101 |
A systematic overview of radiation therapy effects in head and neck cancer. | Acta oncologica (Stockholm, Sweden) 20030101 |
Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU. | British journal of cancer 19820801 |